Placebo-Controlled Trials in the Management of Crohn's Disease: An Umbrella Review of Meta-Analyses.

Med Sci (Basel) · 2025 · PMC11843887 · PMID 39982236

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The clinical response rates seem to depend on dose according to some of the reviewed studies, and one study showed a trend towards mucosal healing (absence of ulceration) at week 12 in patients receiving adalimumab compared to placebo.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.